Indian patients now have access to a new once-weekly insulin alternative. This drug offers a significant reduction in injections from daily to just 52 days annually. Doctors see this as an expansion of treatment options rather than a complete replacement. The weekly insulin is best suited for specific patients requiring basal insulin replacement. While an important advance, other diabetes treatments are also reducing insulin needs.